Best Options Strategy for ENTA
Looking for the best options strategy for Enanta Pharmaceuticals, Inc. (ENTA)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ENTA option chain right now, and a simple map from your view on ENTA to the strategy that fits it. Model any of them in the calculator before you trade.
About ENTA
Enanta Pharmaceuticals, Inc. (ENTA) is a major company in Biotechnology. Options traders on ENTA tend to watch , since these can drive large moves in the share price.
About Enanta Pharmaceuticals, Inc.
# About Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals is a biotechnology company that develops small molecule drugs targeting viral and immune-related diseases. The company's pipeline includes several candidates at various clinical stages: EDP-514 for chronic hepatitis B infection, zelicapavir and EDP-323 for respiratory syncytial virus, EDP-235 for human coronaviruses, EDP-978 for chronic spontaneous urticaria, and EPS-3903 for atopic dermatitis. The company also has glecaprevir, a protease inhibitor antiviral, as part of its portfolio. Through a significant partnership with Abbott Laboratories, Enanta collaborates on the development and commercialization of hepatitis C protease inhibitor compounds, including paritaprevir and glecaprevir, where Enanta supports development and manufacturing efforts.
Enanta generates revenue primarily through its drug development programs and strategic partnerships. The Abbott collaboration represents a key commercial arrangement, providing funding and commercialization support for the company's hepatitis C inhibitor portfolio. As a clinical-stage biotech firm founded in 1995 and based in Watertown, Massachusetts, Enanta's financial model…
Today's top-scoring strategy for ENTA
Our engine ranks defined-risk strategies on the live ENTA chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Sell | 1× | CALL | $16 | $0.09 |
| Buy | 1× | CALL | $17 | $0.01 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Illustrative example at ENTA's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
ENTA is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 32% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on ENTA currently price in about 32% implied volatility, versus roughly 54% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
Off that volatility, the options market is pricing a move of about ±$0.95 (±6%) in ENTA by 2026-07-17 — a range of roughly $14.14 to $16.04. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on ENTA trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
Earnings & IV crush
ENTA's next earnings report is due around August 10, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $439M
- Beta (vs market)
- 0.99
- 52-week range
- $6.43–$17.15 (81% up the range)
- Short interest
- 10.0% of float · 12.1 days to cover
How to choose an options strategy for ENTA
Start with your outlook on ENTA, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while ENTA stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open ENTA in the free calculator →
Frequently asked questions
What is the best options strategy for ENTA?
It depends on your outlook. Bullish traders often use a long call or bull call spread on ENTA; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are ENTA options liquid enough to trade?
Enanta Pharmaceuticals, Inc. (ENTA) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade ENTA options?
Buying a single ENTA call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ENTA or any security. Do your own research.
What does Enanta Pharmaceuticals, Inc. do?
Enanta Pharmaceuticals, Inc. (ENTA) operates in the Biotechnology industry. The "About Enanta Pharmaceuticals, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Enanta Pharmaceuticals, Inc. pay a dividend?
Enanta Pharmaceuticals, Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.
When does Enanta Pharmaceuticals, Inc. next report earnings?
Enanta Pharmaceuticals, Inc.'s next earnings are expected around August 10, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to ENTA
Comparing ENTA with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 4 Kingsbury Avenue, Watertown, MA, 02472, United States
- Industry
- Biotechnology
- Employees
- 120
- CEO
- Dr. Jay R. Luly Ph.D.
- Phone
- 617 607 0800
- Website
- www.enanta.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.